Feasibility of circulating tumor DNA testing in hepatocellular carcinoma

BACKGROUND: Advancement of technologies enabling clinical assessment of circulating tumor DNA (ctDNA) are allowing for assessment of tumor specific genetic alterations in patients. This holds incredible promise for early detection of disease, serial monitoring of tumor heterogeneity, elucidation of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Gastrointest Oncol
Autors principals: Mody, Kabir, Kasi, Pashtoon Murtaza, Yang, Ju Dong, Surapaneni, Phani Keerthi, Ritter, Ashton, Roberts, Ali, Nagy, Rebecca, Borad, Mitesh J.
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6657310/
https://ncbi.nlm.nih.gov/pubmed/31392055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2019.02.10
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars